These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 9815929

  • 1. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A, Aschele C, Mori A, Baldo C, Russo P, Debernardis D, Valenti M, Bruno S, Taverna M, Rosso R.
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [Abstract] [Full Text] [Related]

  • 2. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S, Kubota T, Watanabe M, Furukawa T, Tanino H, Ishibiki K, Teramoto T, Kitajima M.
    Anticancer Res; 1993 Nov; 13(2):369-73. PubMed ID: 8517649
    [Abstract] [Full Text] [Related]

  • 3. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
    Geoffroy FJ, Allegra CJ, Sinha B, Grem JL.
    Oncol Res; 1994 Nov; 6(12):581-91. PubMed ID: 7787251
    [Abstract] [Full Text] [Related]

  • 4. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.
    Aschele C, Sobrero A, Faderan MA, Bertino JR.
    Cancer Res; 1992 Apr 01; 52(7):1855-64. PubMed ID: 1532346
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pretreatment of colon carcinoma cells with Tomudex enhances 5-fluorouracil cytotoxicity.
    Longo GS, Izzo J, Chang YM, Tong WP, Zielinski Z, Gorlick R, Chou TC, Bertino JR.
    Clin Cancer Res; 1998 Feb 01; 4(2):469-73. PubMed ID: 9516938
    [Abstract] [Full Text] [Related]

  • 7. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
    Chu E, Zinn S, Boarman D, Allegra CJ.
    Cancer Res; 1990 Sep 15; 50(18):5834-40. PubMed ID: 1697502
    [Abstract] [Full Text] [Related]

  • 8. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q, Van Groeningen CJ, Hardcastle A, Aherne GW, Geoffroy F, Allegra CJ, Johnston PG, Grem JL.
    Oncol Res; 1997 Sep 15; 9(2):77-88. PubMed ID: 9167189
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ICI D1694 and idoxuridine: a synergistic antitumor combination.
    Pressacco J, Hedley DW, Erlichman C.
    Cancer Res; 1994 Jul 15; 54(14):3772-8. PubMed ID: 8033097
    [Abstract] [Full Text] [Related]

  • 11. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
    Matsuoka H, Furusawa M, Tomoda H, Seo Y, Sugimachi K.
    Anticancer Res; 1993 Jul 15; 13(6A):2201-6. PubMed ID: 8297134
    [Abstract] [Full Text] [Related]

  • 12. Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts.
    Ciccolini J, Peillard L, Evrard A, Cuq P, Aubert C, Pelegrin A, Formento P, Milano G, Catalin J.
    Clin Cancer Res; 2000 Apr 15; 6(4):1529-35. PubMed ID: 10778986
    [Abstract] [Full Text] [Related]

  • 13. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
    Huang Y, Horvath CM, Waxman S.
    Cancer Res; 2000 Jun 15; 60(12):3200-6. PubMed ID: 10866311
    [Abstract] [Full Text] [Related]

  • 14. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.
    Sobrero AF, Aschele C, Guglielmi AP, Mori AM, Melioli GG, Rosso R, Bertino JR.
    J Natl Cancer Inst; 1993 Dec 01; 85(23):1937-44. PubMed ID: 8230285
    [Abstract] [Full Text] [Related]

  • 15. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
    Sakoff JA, Howitt IJ, Ackland SP, McCluskey A.
    Cancer Chemother Pharmacol; 2004 Mar 01; 53(3):225-32. PubMed ID: 14648018
    [Abstract] [Full Text] [Related]

  • 16. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON, Rais R, Shi J, Schinazi RF, Naguib FN, el Kouni MH.
    Cancer Chemother Pharmacol; 2006 Nov 01; 58(5):692-8. PubMed ID: 16528530
    [Abstract] [Full Text] [Related]

  • 17. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
    Tosi P, Calabresi P, Goulette FA, Renaud CA, Darnowski JW.
    Cancer Res; 1992 Aug 01; 52(15):4069-73. PubMed ID: 1638518
    [Abstract] [Full Text] [Related]

  • 18. Combination studies of antifolates with 5-fluorouracil in colon cancer cell lines.
    van der Wilt CL, Kuiper CM, Peters GJ.
    Oncol Res; 1999 Aug 01; 11(8):383-91. PubMed ID: 10803742
    [Abstract] [Full Text] [Related]

  • 19. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA, Morton CL, Adkins DA, Rahman A.
    Cancer Res; 1993 Sep 15; 53(18):4243-50. PubMed ID: 8364921
    [Abstract] [Full Text] [Related]

  • 20. Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.
    Peters GJ, Smitskamp-Wilms E, Smid K, Pinedo HM, Jansen G.
    Cancer Res; 1999 Nov 01; 59(21):5529-35. PubMed ID: 10554030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.